Mouse models for down syndrome-associated developmental cognitive disabilities

Developmental Neuroscience

Volumn 33, Issue 5, 2011, Pages 404-413

  Liu, Chunhong ^a   Belichenko, Pavel V ^c   Zhang, Li ^a   Fu, Dawei ^a   Kleschevnikov, Alexander M ^c   Baldini, Antonio ^d   Antonarakis, Stylianos E ^e   Mobley, William C ^c   Yu, Y Eugene ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^e UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Developmental cognitive disabilities; Down syndrome; Human trisomy 21; Mouse models; Targeted chromosome manipulation

Indexed keywords

COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE MODEL; DOWN SYNDROME; HIPPOCAMPUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; TRISOMY;

ANIMALS; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; DOWN SYNDROME; HUMANS; MICE;

EID: 83055172911     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000329422     Document Type: Review

References (98)

1. Ahn KJ, Jeong HK, Choi HS, Ryoo SR, Kim YJ, Goo JS, Choi SY, Han JS, Ha I, Song WJ (2006): DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiol Dis 22: 463-472.
2. Akeson EC, Lambert JP, Narayanswami S, Gardiner K, Bechtel LJ, Davisson MT (2001): Ts65Dn - localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Cytogenet Cell Genet 93: 270-276.
3. Aldridge K, Reeves RH, Olson LE, Richtsmeier JT (2007): Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am J Med Genet A 143A:1060-1070.
4. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, Bonnen PE, de Bakker PI, Deloukas P, Gabriel SB, Gwilliam R, Hunt S, Inouye M, Jia X, Palotie A, Parkin M, Whittaker P, Chang K, Hawes A, Lewis LR, Ren Y, Wheeler D, Muzny DM, Barnes C, Darvishi K, Hurles M, Korn JM, Kristiansson K, Lee C, McCarrol SA, Nemesh J, Keinan A, Montgomery SB, Pollack S, Price AL, Soranzo N, Gonzaga-Jauregui C, Anttila V, Brodeur W, Daly MJ, Leslie S, McVean G, Moutsianas L, Nguyen H, Zhang Q, Ghori MJ, McGinnis R, McLaren W, Takeuchi F, Grossman SR, Shlyakhter I, Hostetter EB, Sabeti PC, Adebamowo CA, Foster MW, Gordon DR, Licinio J, Manca MC, Marshall PA, Matsuda I, Ngare D, Wang VO, Reddy D, Rotimi CN, Royal CD, Sharp RR, Zeng C, Brooks LD, McEwen JE (2010): Integrating common and rare genetic variation in diverse human populations. Nature 467: 52-58.
5. Andrle M, Fiedler W, Rett A, Ambros P, Schweizer D (1979): A case of trisomy 22 in Pongo pygmaeus . Cytogenet Cell Genet 24: 1-6.
6. Antonarakis SE, Epstein CJ (2006): The challenge of Down syndrome. Trends Mol Med 12: 473-479.
7. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S (2004): Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet 5: 725-738.
8. Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, Dymecki S, Eppig JT, Grieder FB, Heintz N, Hicks G, Insel TR, Joyner A, Koller BH, Lloyd KC, Magnuson T, Moore MW, Nagy A, Pollock JD, Roses AD, Sands AT, Seed B, Skarnes WC, Snoddy J, Soriano P, Stewart DJ, Stewart F, Stillman B, Varmus H, Varticovski L, Verma IM, Vogt TF, von Melchner H, Witkowski J, Woychik RP, Wurst W, Yancopoulos GD, Young SG, Zambrowicz B (2004): The knockout mouse project. Nat Genet 36: 921-924.
9. Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S (2009): Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459: 1126-1130.
10. Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC (2009a): The 'Down syndrome critical region' is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 29: 5938-5948.
11. Belichenko PV, Kleschevnikov AM, Masliah E, Wu C, Takimoto-Kimura R, Salehi A, Mobley WC (2009b): Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome. J Comp Neurol 512: 453-466.
12. Belichenko PV, Kleschevnikov AM, Salehi A, Epstein CJ, Mobley WC (2007): Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. J Comp Neurol 504: 329-345.
13. Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC (2004): Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome. J Comp Neurol 480: 281-298.
14. Besson V, Brault V, Duchon A, Togbe D, Bizot JC, Quesniaux VF, Ryffel B, Herault Y (2007): Modeling the monosomy for the telomeric part of human chromosome 21 reveals haploinsufficient genes modulating the inflammatory and airway responses. Hum Mol Genet 16: 2040-2052.
15. Buehr M, Meek S, Blair K, Yang J, Ure J, Silva J, McLay R, Hall J, Ying QL, Smith A (2008): Capture of authentic embryonic stem cells from rat blastocysts. Cell 135: 1287-1298.
16. Cataldo AM, Petanceska S, Peterhoff CM, Terio NB, Epstein CJ, Villar A, Carlson EJ, Staufenbiel M, Nixon RA (2003): App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of Down syndrome. J Neurosci 23: 6788-6792.
17. Chabert C, Jamon M, Cherfouh A, Duquenne V, Smith DJ, Rubin E, Roubertoux PL (2004): Functional analysis of genes implicated in Down syndrome. 1. Cognitive abilities in mice transpolygenic for Down Syndrome Chromosomal Region-1 (DCR-1). Behav Genet 34: 559-569.
18. Chakrabarti L, Best TK, Cramer NP, Carney RS, Isaac JT, Galdzicki Z, Haydar TF (2010): Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nat Neurosci 13: 927-934.
19. Chakrabarti L, Galdzicki Z, Haydar TF (2007): Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci 27: 11483-11495.
20. Chapman RS, Hesketh LJ (2000): Behavioral phenotype of individuals with Down syndrome. Ment Retard Dev Disabil Res Rev 6: 84-95.
21. Cowles CR, Hirschhorn JN, Altshuler D, Lander ES (2002): Detection of regulatory variation in mouse genes. Nat Genet 32: 432-437.
22. Cragg BG (1975): The density of synapses and neurons in normal, mentally defective ageing human brains. Brain 98: 81-90.
23. Davisson MT, Schmidt C, Akeson EC (1990): Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res 360: 263-280.
24. DeFelipe J, Farinas I (1992): The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol 39: 563-607.
25. Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, Noel B, Sinet PM (1993): Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet 1: 114-124.
26. Deplancke B, Mukhopadhyay A, Ao W, Elewa AM, Grove CA, Martinez NJ, Sequerra R, Doucette-Stamm L, Reece-Hoyes JS, Hope IA, Tissenbaum HA, Mango SE, Walhout AJ (2006): A gene-centered C. elegans protein- DNA interaction network. Cell 125: 1193-1205.
27. de Waal FB, Uno H, Luttrell LM, Meisner LF, Jeannotte LA (1996): Behavioral retardation in a macaque with autosomal trisomy and aging mother. Am J Ment Retard 100: 378-390.
28. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C, Attar-Cohen H, Ingle C, Beazley C, Gutierrez Arcelus M, Sekowska M, Gagnebin M, Nisbett J, Deloukas P, Dermitzakis ET, Antonarakis SE (2009): Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325: 1246-1250.
29. Duchon A, Pothion S, Brault V, Sharp AJ, Tybulewicz VL, Fisher EM, Herault Y (2010): The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessarry for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome. Behav Brain Res 217: 271-281.
30. Epstein CJ (1986): The Consequences of Chromosome Imbalance: Principles, Mechanism and Models. New York, Cambridge University Press.
31. Fernandez F, Morishita W, Zuniga E, Nguyen J, Blank M, Malenka RC, Garner CC (2007): Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci 10: 411-413.
32. Ferrer I, Gullotta F (1990): Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus. Acta Neuropathol 79: 680-685.
33. Fiala JC, Spacek J, Harris KM (2002): Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Brain Res Rev 39:29-54.
34. Finelli A, Kelkar A, Song HJ, Yang H, Konsolaki M (2004): A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster . Mol Cell Neurosci 26: 365-375.
35. Gardiner K, Fortna A, Bechtel L, Davisson MT (2003): Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 318: 137-147.
36. Gardiner K, Herault Y, Lott IT, Antonarakis SE, Reeves RH, Dierssen M (2010): Down syndrome: from understanding the neurobiology to therapy. J Neurosci 30: 14943-14945.
37. Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Mil ler JC, Choi VM, Jenkins SS, Wood A, Cui X, Meng X, Vincent A, Lam S, Michalkiewicz M, Schilling R, Foeckler J, Kalloway S, Weiler H, Menoret S, Anegon I, Davis GD, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Jacob HJ, Buelow R (2009): Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325: 433.
38. Gray EG (1959): Electron microscopy of synaptic contacts on dendrite spines of the cerebral cortex. Nature 183: 1592-1593.
39. Haxby JV (1989): Neuropsychological evaluation of adults with Down's syndrome: patterns of selective impairment in non-dementedold adults. J Ment Defic Res 33: 193-210.
40. Heller HC, Colas D, Ruby NF, Fernandez F, Chuluun B, Blank M, Garner CC (2009): Long term repair of learning disability through short-term reduction of CNS inhibition; in Schmorrow DD, Estabrookse IV, Grootjen M (eds): Foundations of Augmented Cognition, Neuroergonomics and Operational Neuroscience. New York, Springer, pp 818-825.
41. Hernandez D, Mee PJ, Martin JE, Tybulewicz VL, Fisher EM (1999): Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21. Hum Mol Genet 8: 923-933.
42. Inoue T, Shinohara T, Takehara S, Inoue J, Kamino H, Kugoh H, Oshimura M (2000): Specific impairment of cardiogenesis in mouse ES cells containing a human chromosome 21. Biochem Biophys Res Commun 273: 219-224.
43. Kahlem P, Sultan M, Herwig R, Steinfath M, Balzereit D, Eppens B, Saran NG, Pletcher MT, South ST, Stetten G, Lehrach H, Reeves RH, Yaspo ML (2004): Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of Down syndrome. Genome Res 14: 1258-1267.
44. Kazuki Y, Schulz TC, Shinohara T, Kadota M, Nishigaki R, Inoue T, Kimura M, Kai Y, Abe S, Shirayoshi Y, Oshimura M (2003): A new mouse model for Down syndrome; in Lubec G (ed): Advances in Down Syndrome Research. Wien, Springer, pp 1-20.
45. Kleschevnikov AM, Belichenko PV, Villar AJ, Epstein CJ, Malenka RC, Mobley WC (2004): Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci 24: 8153-8160.
46. Korenberg JR, Chen XN, Schipper R, Sun Z, Gonsky R, Gerwehr S, Carpenter N, Daumer C, Dignan P, Disteche C (1994): Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA 91: 4997-5001.
47. Laffaire J, Rivals I, Dauphinot L, Pasteau F, Wehrle R, Larrat B, Vitalis T, Moldrich RX, Rossier J, Sinkus R, Herault Y, Dusart I, Potier MC (2009): Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development. BMC Genomics 10: 138.
48. Li P, Tong C, Mehrian-Shai R, Jia L, Wu N, Yan Y, Maxson RE, Schulze EN, Song H, Hsieh CL, Pera MF, Ying QL (2008): Germline competent embryonic stem cells derived from rat blastocysts. Cell 135: 1299-1310.
49. Li Z, Yu T, Morishima M, Pao A, LaDuca J, Conroy J, Nowak N, Matsui S, Shiraishi I, Yu Y (2007): Duplication of the entire 22.9-Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet 16: 1359-1366.
50. Lyle R, Gehrig C, Neergaard-Henrichsen C, Deutsch S, Antonarakis SE (2004): Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome. Genome Res 14: 1268-1274.
51. Marin-Padilla M (1972): Structural abnormalities of the cerebral cortex in human chromosomal aberrations: a Golgi study. Brain Res 44: 625-629.
52. Marin-Padilla M (1976): Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study. J Comp Neurol 167: 63-81.
53. McClure HM (1972): Animal model: trisomy in a chimpanzee. Am J Pathol 67: 413-416
54. McClure HM, Belden KH, Pieper WA, Jacobson CB (1969): Autosomal trisomy in a chimpanzee: resemblance to Down's syndrome. Science 165: 1010-1012.
55. Moldrich RX (2007): A yeast model of Down syndrome. Int J Dev Neurosci 25: 539-543.
56. Montgomery SB, Sammeth M, Gutierrez-Arcelus M, Lach RP, Ingle C, Nisbett J, Guigo R, Dermitzakis ET (2010): Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 464: 773-777.
57. Morice E, Andreae LC, Cooke SF, Vanes L, Fisher EM, Tybulewicz VL, Bliss TV (2008): Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. Learn Mem 15: 492-500.
58. Nadel L (1999): Down syndrome in cognitive neuroscience perspective; in Tager-Flusberg H (ed): Neurodeveolpmental Disorders. Cambridge, MIT Press, pp 197-221.
59. North TE, Zon LI (2003): Modeling human hematopoietic and cardiovascular diseases in zebrafish. Dev Dyn 228: 568-583.
60. O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, Sesay A, Modino S, Vanes L, Hernandez D, Linehan JM, Sharpe PT, Brandner S, Bliss TV, Henderson DJ, Nizetic D, Tybulewicz VL, Fisher EM (2005): An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309: 2033-2037.
61. Olson LE, Richtsmeier JT, Leszl J, Reeves RH (2004a): A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306: 687-690.
62. Olson LE, Roper RJ, Baxter LL, Carlson EJ, Epstein CJ, Reeves RH (2004b): Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev Dyn 230: 581-589.
63. Pennington BF, Moon J, Edgin J, Stedron J, Nadel L (2003): The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev 74: 75-93.
64. Pereira PL, Magnol L, Sahun I, Brault V, Duchon A, Prandini P, Gruart A, Bizot JC, Chadefaux- Vekemans B, Deutsch S, Trovero F, Delgado- Garcia JM, Antonarakis SE, Dierssen M, Herault Y (2009): A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. Hum Mol Genet 18: 4756-4769.
65. Pickrell JK, Marioni JC, Pai AA, Degner JF, Engelhardt BE, Nkadori E, Veyrieras JB, Stephens M, Gilad Y, Pritchard JK (2010): Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464: 768-772.
66. Popov VI, Kleschevnikov AM, Klimenko OA, Stewart MG, Belichenko PV (2011): Threedimensional synaptic ultrastructure in the dentate gyrus and CA3 hippocampal area in the Ts65Dn mouse model of Down syndrome. J Comp Neurol 519: 1338-1354.
67. Pulsifer MB (1996): The neuropsychology of mental retardation. J Int Neuropsychol Soc 2: 159-176.
68. Purpura DP (1975): Normal and aberrant neuronal development in the cerebral cortex of human fetus and young infant. UCLA Forum Med Sci 141-169.
69. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT (1995): A mouse model for Down syndrome exhibits learning and behavior deficits. Nat Genet 11: 177-184.
70. Roizen NJ, Patterson D (2003): Down's syndrome. Lancet 361: 1281-1289.
71. Ross MH, Galaburda AM, Kemper TL (1984): Down's syndrome: is there a decreased population of neurons? Neurology 34: 909-916.
72. Roubertoux PL, Carlier M (2010): Mouse models of cognitive disabilities in trisomy 21 (Down syndrome). Am J Med Genet C Semin Med Genet 154C:400-416.
73. Ruppenthal GC, Caffery SA, Goodlin BL, Sackett GP, Vigfusson NV, Peterson VG (1983): Pigtailed macaques (Macaca nemestrina) with trisomy X manifest physical and mental retardation. Am J Ment Defic 87: 471-476.
74. Ruppenthal GC, Caffery SA, Goodlin BL, Sackett GP, Vigfusson NV, Peterson VG (1986): Pigtailed macaques (Macaca nemestrina) with trisomy X manifest physical and mental retardation. Erratum. Am J Ment Defic 90: 362.
75. Sago H, Carlson EJ, Smith DJ, Kilbridge J, Rubin EM, Mobley WC, Epstein CJ, Huang TT (1998): Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci USA 95: 6256-6261.
76. Sago H, Carlson EJ, Smith DJ, Rubin EM, Crnic LS, Huang TT, Epstein CJ (2000): Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr Res 48: 606-613.
77. Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC (2006): Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51: 29-42.
78. Schmidt-Sidor B, Wisniewski KE, Shepard TH, Sersen EA (1990): Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin Neuropathol 9: 181-190.
79. Shinohara T, Tomizuka K, Miyabara S, Takehara S, Kazuki Y, Inoue J, Katoh M, Nakane H, Iino A, Ohguma A, Ikegami S, Inokuchi K, Ishida I, Reeves RH, Oshimura M (2001): Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Hum Mol Genet 10: 1163-1175.
80. Siarey RJ, Stoll J, Rapoport SI, Galdzicki Z (1997): Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome. Neuropharmacology 36: 1549-1554.
81. Sinet PM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, Noel B, Delabar JM (1993): Molecular mapping of the Down syndrome phenotype on chromosome 21. Prog Clin Biol Res 384: 63-86.
82. Smith DJ, Stevens ME, Sudanagunta SP, Bronson RT, Makhinson M, Watabe AM, O'Dell TJ, Fung J, Weier HU, Cheng JF, Rubin EM (1997): Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet 16: 28-36.
83. Smith DJ, Zhu Y, Zhang J, Cheng JF, Rubin EM (1995): Construction of a panel of transgenic mice containing a contiguous 2-Mb set of YAC/P1 clones from human chromosome 21q22.2. Genomics 27: 425-434.
84. Suetsugu M, Mehraein P (1980): Spine distribution along the apical dendrites of the pyramidal neurons in Down's syndrome. A quantitative Golgi study. Acta Neuropathol 50: 207-210.
85. Sussan TE, Yang A, Li F, Ostrowski MC, Reeves RH (2008): Trisomy represses Apc(Min)- mediated tumours in mouse models of Down's syndrome. Nature 451: 73-75.
86. Takashima S, Becker LE, Armstrong DL, Chan F (1981): Abnormal neuronal development in the visual cortex of the human fetus and infant with Down's syndrome. A quantitative and qualitative Golgi study. Brain Res 225: 1-21.
87. Takashima S, Iida K, Mito T, Arima M (1994): Dendritic and histochemical development and ageing in patients with Down's syndrome. J Intellect Disabil Res 38: 265-273.
88. Tong C, Li P, Wu NL, Yan Y, Ying QL (2010): Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature 467: 211-213.
89. Uecker A, Mangan PA, Obrzut JE, Nadel L (1993): Down syndrome in neurobiological perspective: an emphasis on spatial cognition. J Clin Child Psychol 22: 266-276.
90. Wade CM, Kulbokas EJ, 3rd, Kirby AW, Zody MC, Mullikin JC, Lander ES, Lindblad-Toh K, Daly MJ (2002): The mosaic structure of variation in the laboratory mouse genome. Nature 420: 574-578
91. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, Dewey C, Dickens NJ, Diekhans M, Dodge S, Dubchak I, Dunn DM, Eddy SR, Elnitski L, Emes RD, Eswara P, Eyras E, Felsenfeld A, Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey TS, Gage D, Gibbs RA, Glusman G, Gnerre S, Goldman N, Goodstadt L, Grafham D, Graves TA, Green ED, Gregory S, Guigo R, Guyer M, Hardison RC, Haussler D, Hayashizaki Y, Hillier LW, Hinrichs A, Hlavina W, Holzer T, Hsu F, Hua A, Hubbard T, Hunt A, Jackson I, Jaffe DB, Johnson LS, Jones M, Jones TA, Joy A, Kamal M, Karlsson EK, Karolchik D, Kasprzyk A, Kawai J, Keibler E, Kells C, Kent WJ, Kirby A, Kolbe DL, Korf I, Kucherlapati RS, Kulbokas EJ, Kulp D, Landers T, Leger JP, Leonard S, Letunic I, Levine R, Li J, Li M, Lloyd C, Lucas S, Ma B, Maglott DR, Mardis ER, Matthews L, Mauceli E, Mayer JH, Mc- Carthy M, McCombie WR, McLaren S, McLay K, McPherson JD, Meldrim J, Meredith B, Mesirov JP, Miller W, Miner TL, Mongin E, Montgomery KT, Morgan M, Mott R, Mullikin JC, Muzny DM, Nash WE, Nelson JO, Nhan MN, Nicol R, Ning Z, Nusbaum C, O'Connor MJ, Okazaki Y, Oliver K, Overton-Larty E, Pachter L, Parra G, Pepin KH, Peterson J, Pevzner P, Plumb R, Pohl CS, Poliakov A, Ponce TC, Ponting CP, Potter S, Quail M, Reymond A, Roe BA, Roskin KM, Rubin EM, Rust AG, Santos R, Sapojnikov V, Schultz B, Schultz J, Schwartz MS, Schwartz S, Scott C, Seaman S, Searle S, Sharpe T, Sheridan A, Shownkeen R, Sims S, Singer JB, Slater G, Smit A, Smith DR, Spencer B, Stabenau A, Stange-Thomann N, Sugnet C, Suyama M, Tesler G, Thompson J, Torrents D, Trevaskis E, Tromp J, Ucla C, Ureta-Vidal A, Vinson JP, Von Niederhausern AC, Wade CM, Wall M, Weber RJ, Weiss RB, Wendl MC, West AP, Wetterstrand K, Wheeler R, Whelan S, Wierzbowski J, Willey D, Williams S, Wilson RK, Winter E, Worley KC, Wyman D, Yang S, Yang SP, Zdobnov EM, Zody MC, Lander ES (2002): Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-562.
92. Wisniewski KE (1990): Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am J Med Genet Suppl 7: 274-281.
93. Wurst W (2005): Mouse geneticists need European strategy too. Nature 433: 13.
94. Yang SH, Cheng PH, Banta H, Piotrowska- Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW (2008): Towards a transgenic model of Huntington's disease in a non-human primate. Nature 453: 921-924.
95. Yu T, Clapcote SJ, Li Z, Liu C, Pao A, Bechard AR, Carattini-Rivera S, Matsui S, Roder JC, Baldini A, Mobley WC, Bradley A, Yu YE (2010a): Deficiencies in the region syntenic to human 21q22.3 cause cognitive deficits in mice. Mamm Genome 21: 258-267.
96. Yu T, Li Z, Jia Z, Clapcote SJ, Liu C, Li S, Asrar S, Pao A, Chen R, Fan N, Carattini-Rivera S, Bechard AR, Spring S, Henkelman RM, Stoica G, Matsui S, Nowak NJ, Roder JC, Chen C, Bradley A, Yu YE (2010b): A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet 19: 2780-2791.
97. Yu T, Liu C, Belichenko P, Clapcote SJ, Li S, Pao A, Kleschevnikov A, Bechard AR, Asrar S, Chen R, Fan N, Zhou Z, Jia Z, Chen C, Roder JC, Liu B, Baldini A, Mobley WC, Yu YE (2010c): Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Res 1366: 162-171.
98. Yu Y, Bradley A (2001): Engineering chromosomalrearrangements in mice. Nat Rev Genet 2: 780-790.